Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | DrugBank | Drug (Description in trials) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 |
Aldesleukin
(125-L-serine-2-133-interleukin 2) | [4] ALDESLEUKIN ALDESLEUKIN; ILT-101; Proleukin; Recombinant human interleukin-2 | [1] Aldesleukin
Aldesleukin
💬
| [3] IL2RA IL2RA,IL2RB, IL2RG 💬 | [14] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [6] 2 2, 35, 49, 65, 96, 97 💬
|
| 2 |
Serine
(L-Serine) | [2] L-Serine L-Serine; Serine | [1] Serine
Serine
(L-Serine (JP18)) 💬
| - | - | [4] 2 2, 6, 86, 96 💬
|